These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 28050622)
1. Correlation between quantitative and semiquantitative parameters in DCE-MRI with a blood pool agent in rectal cancer: can semiquantitative parameters be used as a surrogate for quantitative parameters? Dijkhoff RAP; Maas M; Martens MH; Papanikolaou N; Lambregts DMJ; Beets GL; Beets-Tan RGH Abdom Radiol (NY); 2017 May; 42(5):1342-1349. PubMed ID: 28050622 [TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment. Ciolina M; Caruso D; De Santis D; Zerunian M; Rengo M; Alfieri N; Musio D; De Felice F; Ciardi A; Tombolini V; Laghi A Radiol Med; 2019 May; 124(5):331-338. PubMed ID: 30560501 [TBL] [Abstract][Full Text] [Related]
3. Value of DCE-MRI for staging and response evaluation in rectal cancer: A systematic review. Dijkhoff RAP; Beets-Tan RGH; Lambregts DMJ; Beets GL; Maas M Eur J Radiol; 2017 Oct; 95():155-168. PubMed ID: 28987662 [TBL] [Abstract][Full Text] [Related]
4. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results. Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980 [TBL] [Abstract][Full Text] [Related]
6. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer. Gollub MJ; Tong T; Weiser M; Zheng J; Gonen M; Zakian KL Eur Radiol; 2017 Apr; 27(4):1605-1612. PubMed ID: 27436029 [TBL] [Abstract][Full Text] [Related]
7. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563 [TBL] [Abstract][Full Text] [Related]
9. In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats. Bolcaen J; Descamps B; Acou M; Deblaere K; den Broecke CV; Boterberg T; Vanhove C; Goethals I Mol Imaging Biol; 2017 Dec; 19(6):857-866. PubMed ID: 28303489 [TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer. Kim SH; Lee JM; Gupta SN; Han JK; Choi BI J Magn Reson Imaging; 2014 Sep; 40(3):730-7. PubMed ID: 24307571 [TBL] [Abstract][Full Text] [Related]
11. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI. Zou HH; Yu J; Wei Y; Wu JF; Xu Q J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601 [TBL] [Abstract][Full Text] [Related]
12. Correlations of dynamic contrast-enhanced magnetic resonance imaging with morphologic, angiogenic, and molecular prognostic factors in rectal cancer. Hong HS; Kim SH; Park HJ; Park MS; Kim KW; Kim WH; Kim NK; Lee JM; Cho HJ Yonsei Med J; 2013 Jan; 54(1):123-30. PubMed ID: 23225808 [TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293 [TBL] [Abstract][Full Text] [Related]
14. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters. Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761 [TBL] [Abstract][Full Text] [Related]
15. Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer. Yu J; Xu Q; Huang DY; Song JC; Li Y; Xu LL; Shi HB Eur Radiol; 2017 May; 27(5):1840-1847. PubMed ID: 27595835 [TBL] [Abstract][Full Text] [Related]
16. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer. Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852 [TBL] [Abstract][Full Text] [Related]
17. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate. Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282 [TBL] [Abstract][Full Text] [Related]